Dampened ERK signaling in hematopoietic progenitor cells in rheumatoid arthritis.

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Inés ColmegnaCornelia M Weyand

Abstract

In rheumatoid arthritis (RA), hematopoietic progenitor cells (HPC) have age-inappropriate telomeric shortening suggesting premature senescence and possible restriction of proliferative capacity. In response to hematopoietic growth factors RA-derived CD34(+) HPC expanded significantly less than age-matched controls. Cell surface receptors for stem cell factor (SCF), Flt 3-Ligand, IL-3 and IL-6 were intact in RA HPC but the cells had lower transcript levels of cell cycle genes, compatible with insufficient signal strength in the ERK pathway. Cytokine-induced phosphorylation of ERK1/2 was diminished in RA HPC whereas phosphorylated STAT3 and STAT5 molecules accumulated to a similar extent as in controls. Confocal microscopy demonstrated that the membrane-proximal colocalization of K-Ras and B-Raf was less efficient in RA-derived CD34(+) cells. Thus, hyporesponsiveness of RA HPC to growth factors results from dampening of the ERK signaling pathways; with a defect localized in the very early steps of the ERK signaling cascade.

References

Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K AndoJ D Griffin
Nov 1, 2000·Cell·J Schlessinger
Aug 3, 2002·Leukemia & Lymphoma·Helen A PapadakiGeorge D Eliopoulos
Oct 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Stefan O SchönlandCornelia M Weyand
Nov 5, 2004·Cellular and Molecular Life Sciences : CMLS·L Rönnstrand
Mar 9, 2005·Trends in Cell Biology·Mark J MurphyAndreas Trumpp
Sep 17, 2005·Leukemia Research·Michelle B MirandaDaniel E Johnson
Nov 28, 2006·Biochimica Et Biophysica Acta·James A McCubreyRichard A Franklin
Feb 20, 2007·Biochimica Et Biophysica Acta·Menachem KatzYosef Yarden
Jul 10, 2007·Nature Cell Biology·Tianhai TianJohn F Hancock
Aug 3, 2007·Nature Cell Biology·Anne K Kenworthy
Aug 7, 2007·PLoS Biology·Stuart M ChambersMargaret A Goodell
Dec 7, 2007·Genes & Development·Julian A Martinez-AgostoUtpal Banerjee
Jan 10, 2008·Blood·Donald Metcalf
Feb 26, 2008·Cell·Derrick J RossiIrving L Weissman
May 6, 2008·Best Practice & Research. Clinical Rheumatology·Claire L Gorman, Andrew P Cope
Oct 11, 2008·Cell Death and Differentiation·K Balmanno, S J Cook
Mar 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi FujiiCornelia M Weyand
Oct 3, 2009·Nature Reviews. Rheumatology·Cornelia M WeyandJörg J Goronzy
Oct 20, 2009·Arthritis Research & Therapy·Jörg J Goronzy, Cornelia M Weyand
Sep 30, 2010·EMBO Molecular Medicine·Lan ShaoCornelia M Weyand

❮ Previous
Next ❯

Citations

Apr 2, 2014·Mayo Clinic Proceedings·Philipp J HohensinnerCornelia M Weyand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

© 2022 Meta ULC. All rights reserved